{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T21:14:13Z","timestamp":1763414053757,"version":"3.45.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100008376","name":"Helsingin ja Uudenmaan Sairaanhoitopiiri","doi-asserted-by":"publisher","award":["TYH2025468"],"award-info":[{"award-number":["TYH2025468"]}],"id":[{"id":"10.13039\/100008376","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010135","name":"Finska L\u00e4kares\u00e4llskapet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010135","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010116","name":"Medicinska Underst\u00f6dsf\u00f6reningen Liv och H\u00e4lsa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010116","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007247","name":"Svenska Kulturfonden","doi-asserted-by":"publisher","award":["199123"],"award-info":[{"award-number":["199123"]}],"id":[{"id":"10.13039\/501100007247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007639","name":"Maire Taposen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007639","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007797","name":"University of Helsinki","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007797","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-025-09133-w","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T18:27:47Z","timestamp":1763404067000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Restarting anticoagulation early versus late\u00a0in patients with chronic\u00a0subdural hematoma and\u00a0atrial fibrillation (RELACS): a phase III international\u00a0multicenter, randomized controlled, two-arm, assessor-blinded trial"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4243-9591","authenticated-orcid":false,"given":"Rahul","family":"Raj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pihla","family":"Tommiska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riku","family":"Kivisaari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miikka","family":"Korja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teemu","family":"Luostarinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyri J.","family":"Virta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simo","family":"Taimela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teppo L.N","family":"J\u00e4rvinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Niemel\u00e4","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timo","family":"Koivisto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ville","family":"Leinonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bjartur","family":"Saemundsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Fletcher-Sandersj\u00f6\u00f6","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommi","family":"Korhonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sami","family":"Tetri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minna","family":"Rauhala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Laukka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Czuba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiri","family":"Bartek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils","family":"Danner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oula","family":"Knuutinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teemu","family":"Luoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jussi P.","family":"Posti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarno","family":"Satop\u00e4\u00e4","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"9133_CR1","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.3171\/2014.9.JNS141550","volume":"123","author":"D Balser","year":"2015","unstructured":"Balser D, Farooq S, Mehmood T, Reyes M, Samadani U. Actual and projected incidence rates for chronic subdural hematomas in United States veterans administration and civilian populations. J Neurosurg. 2015;123:1209\u201315.","journal-title":"J Neurosurg"},{"key":"9133_CR2","doi-asserted-by":"crossref","unstructured":"Rauhala M, Luoto TM, Huhtala H, Iverson GL, Niskakangas T, \u00d6hman J, et al. The incidence of chronic subdural hematomas from 1990 to 2015 in a defined Finnish population. J Neurosurg. 2019;132:1147\u201357","DOI":"10.3171\/2018.12.JNS183035"},{"key":"9133_CR3","doi-asserted-by":"crossref","unstructured":"Tommiska P, Luostarinen T, Kaprio J, Korja M, L\u00f6nnrot K, Kivisaari R, et al. Incidence of surgery for chronic subdural hematoma in Finland during 1997\u20132014: a nationwide study. J Neurosurg. 2021;136:1886\u201393.","DOI":"10.3171\/2021.3.JNS21281"},{"key":"9133_CR4","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1001\/jama.2017.0639","volume":"317","author":"D Gaist","year":"2017","unstructured":"Gaist D, Garc\u00eda Rodr\u00edguez LA, Hellfritzsch M, Poulsen FR, Halle B, Hallas J, et al. Association of antithrombotic drug use with subdural hematoma risk. JAMA. 2017;317:836\u201346.","journal-title":"JAMA"},{"key":"9133_CR5","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1056\/NEJMoa2216767","volume":"388","author":"IP Miah","year":"2023","unstructured":"Miah IP, Holl DC, Blaauw J, Lingsma HF, den Hertog HM, Jacobs B, et al. Dexamethasone versus surgery for chronic subdural hematoma. N Engl J Med. 2023;388:2230\u201340.","journal-title":"N Engl J Med"},{"key":"9133_CR6","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1056\/NEJMoa2020473","volume":"383","author":"PJ Hutchinson","year":"2020","unstructured":"Hutchinson PJ, Edlmann E, Bulters D, Zolnourian A, Holton P, Suttner N, et al. Trial of dexamethasone for chronic subdural hematoma. N Engl J Med. 2020;383:2616\u201327.","journal-title":"N Engl J Med"},{"key":"9133_CR7","unstructured":"Raj R, Tommiska P, Koivisto T, Leinonen V, Danner N, Posti JP, et al. Burr-hole drainage with or without irrigation for chronic subdural haematoma (FINISH): a Finnish, nationwide, parallel-group, multicentre, randomised, controlled, non-inferiority trial. Lancet Lond Engl. 2024;S0140\u20136736(24)00686-X."},{"key":"9133_CR8","unstructured":"Gr\u00f8nh\u00f8j MH, Jensen TSR, Miscov R, Sindby AK, Debrabant B, Hundsholt T, et al. Optimal drainage time after evacuation of chronic subdural haematoma (DRAIN TIME 2): a multicentre, randomised, multiarm and multistage non-inferiority trial in Denmark. Lancet Neurol. 2024;0. Available from: https:\/\/www.thelancet.com\/journals\/laneur\/article\/PIIS1474-4422(24)00175-3\/abstract. Cited 16 Jun 2024."},{"key":"9133_CR9","volume":"85","author":"J Soleman","year":"2019","unstructured":"Soleman J, Lutz K, Schaedelin S, Kamenova M, Guzman R, Mariani L, et al. Subperiosteal vs subdural drain after burr-hole drainage of chronic subdural hematoma: a randomized clinical trial (cSDH-drain-trial). Neurosurgery. 2019;85:E825\u201334.","journal-title":"Neurosurgery"},{"key":"9133_CR10","doi-asserted-by":"crossref","unstructured":"Krijthe B, Kunst A, Benjamin E, Lip G, Franco F, Hofman A, et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J. 2013;34. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/23900699\/. Cited 16 Jun 2024.","DOI":"10.1093\/eurheartj\/eht280"},{"key":"9133_CR11","doi-asserted-by":"crossref","unstructured":"Miyasaka Y, Barnes M, Gersh B, Cha S, Bailey K, Abhayaratna W, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/16818816\/.\u00a0Cited 16 Jun 2024.","DOI":"10.1161\/CIRCULATIONAHA.105.595140"},{"key":"9133_CR12","doi-asserted-by":"publisher","first-page":"750","DOI":"10.3171\/2015.2.JNS141889","volume":"124","author":"D Guha","year":"2016","unstructured":"Guha D, Coyne S, Macdonald RL. Timing of the resumption of antithrombotic agents following surgical evacuation of chronic subdural hematomas: a retrospective cohort study. J Neurosurg. 2016;124:750\u20139.","journal-title":"J Neurosurg"},{"key":"9133_CR13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3109\/02688697.2013.812184","volume":"28","author":"A Chari","year":"2014","unstructured":"Chari A, Clemente Morgado T, Rigamonti D. Recommencement of anticoagulation in chronic subdural haematoma: a systematic review and meta-analysis. Br J Neurosurg. 2014;28:2\u20137.","journal-title":"Br J Neurosurg"},{"key":"9133_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.clineuro.2016.10.002","volume":"151","author":"T Amano","year":"2016","unstructured":"Amano T, Takahara K, Maehara N, Shimogawa T, Mukae N, Sayama T, et al. Optimal perioperative management of antithrombotic agents in patients with chronic subdural hematoma. Clin Neurol Neurosurg. 2016;151:43\u201350.","journal-title":"Clin Neurol Neurosurg"},{"key":"9133_CR15","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1007\/s00701-022-05337-0","volume":"164","author":"S Kerttula","year":"2022","unstructured":"Kerttula S, Huttunen J, Leinonen V, K\u00e4m\u00e4r\u00e4inen O-P, Danner N. The effect of antithrombotic therapy on the recurrence and outcome of chronic subdural hematoma after burr-hole craniostomy in a population-based cohort. Acta Neurochir (Wien). 2022;164:2699\u2013708.","journal-title":"Acta Neurochir (Wien)"},{"key":"9133_CR16","first-page":"31","volume":"77","author":"MJ Mirzayan","year":"2016","unstructured":"Mirzayan MJ, Calvelli K, Capelle H-H, Weigand J, Krauss JK. Subdural hematoma and oral anticoagulation: a therapeutic dilemma from the neurosurgical point of view. J Neurol Surg Part Cent Eur Neurosurg. 2016;77:31\u20135.","journal-title":"J Neurol Surg Part Cent Eur Neurosurg"},{"key":"9133_CR17","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.wneu.2017.01.065","volume":"100","author":"M Kamenova","year":"2017","unstructured":"Kamenova M, Nevzati E, Lutz K, Dolp A, Fandino J, Mariani L, et al. Burr-hole drainage for chronic subdural hematoma under low-dose acetylsalicylic acid: a comparative risk analysis study. World Neurosurg. 2017;100:594\u2013600.","journal-title":"World Neurosurg"},{"key":"9133_CR18","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1227\/NEU.0000000000001393","volume":"79","author":"M Kamenova","year":"2016","unstructured":"Kamenova M, Lutz K, Schaedelin S, Fandino J, Mariani L, Soleman J. Does early resumption of low-dose aspirin after evacuation of chronic subdural hematoma with burr-hole drainage lead to higher recurrence rates? Neurosurgery. 2016;79:715\u201321.","journal-title":"Neurosurgery"},{"key":"9133_CR19","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1007\/s00701-017-3330-x","volume":"159","author":"I Fornebo","year":"2017","unstructured":"Fornebo I, Sj\u00e5vik K, Alibeck M, Kristiansson H, St\u00e5hl F, F\u00f6rander P, et al. Role of antithrombotic therapy in the risk of hematoma recurrence and thromboembolism after chronic subdural hematoma evacuation: a population-based consecutive cohort study. Acta Neurochir (Wien). 2017;159:2045\u201352.","journal-title":"Acta Neurochir (Wien)"},{"key":"9133_CR20","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1056\/NEJMc1812507","volume":"380","author":"P Schucht","year":"2019","unstructured":"Schucht P, Fischer U, Fung C, Bernasconi C, Fichtner J, Vulcu S, et al. Follow-up computed tomography after evacuation of chronic subdural hematoma. N Engl J Med. 2019;380:1186\u20137.","journal-title":"N Engl J Med"},{"key":"9133_CR21","doi-asserted-by":"publisher","DOI":"10.1227\/neu.0000000000001997","author":"J Duerinck","year":"2022","unstructured":"Duerinck J, Van Der Veken J, Schuind S, Van Calenbergh F, van Loon J, Du Four S, et al. Randomized trial comparing burr hole craniostomy, minicraniotomy, and twist drill craniostomy for treatment of chronic subdural hematoma. Neurosurgery. 2022. https:\/\/doi.org\/10.1227\/neu.0000000000001997.","journal-title":"Neurosurgery"},{"key":"9133_CR22","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/S0140-6736(09)61115-6","volume":"374","author":"T Santarius","year":"2009","unstructured":"Santarius T, Kirkpatrick PJ, Ganesan D, Chia HL, Jalloh I, Smielewski P, et al. Use of drains versus no drains after burr-hole evacuation of chronic subdural haematoma: a randomised controlled trial. Lancet. 2009;374:1067\u201373.","journal-title":"Lancet"},{"key":"9133_CR23","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1001\/jamaneurol.2022.4133","volume":"80","author":"A Bartley","year":"2023","unstructured":"Bartley A, Bartek J Jr, Jakola AS, Sundblom J, F\u00e4lt M, F\u00f6rander P, et al. Effect of irrigation fluid temperature on recurrence in the evacuation of chronic subdural hematoma: a randomized clinical trial. JAMA Neurol. 2023;80:58\u201363.","journal-title":"JAMA Neurol"},{"key":"9133_CR24","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1212\/WNL.0000000000003918","volume":"88","author":"S Nathan","year":"2017","unstructured":"Nathan S, Goodarzi Z, Jette N, Gallagher C, Holroyd-Leduc J. Anticoagulant and antiplatelet use in seniors with chronic subdural hematoma: systematic review. Neurology. 2017;88:1889\u201393.","journal-title":"Neurology"},{"key":"9133_CR25","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12883-021-02126-7","volume":"21","author":"A Prior","year":"2021","unstructured":"Prior A, Fiaschi P, Iaccarino C, Stefini R, Battaglini D, Balestrino A, et al. How do you manage ANTICOagulant therapy in neurosurgery? The ANTICO survey of the Italian Society of Neurosurgery (SINCH). BMC Neurol. 2021;21:98.","journal-title":"BMC Neurol"},{"key":"9133_CR26","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013972","volume":"98","author":"H Wang","year":"2019","unstructured":"Wang H, Zhang M, Zheng H, Xia X, Luo K, Guo F, et al. The effects of antithrombotic drugs on the recurrence and mortality in patients with chronic subdural hematoma: A meta-analysis. Medicine (Baltimore). 2019;98:e13972.","journal-title":"Medicine (Baltimore)"},{"key":"9133_CR27","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S1474-4422(07)70031-5","volume":"6","author":"K Strong","year":"2007","unstructured":"Strong K, Mathers C, Bonita R. Preventing stroke: saving lives around the world. Lancet Neurol. 2007;6:182\u20137.","journal-title":"Lancet Neurol"},{"key":"9133_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-024-06417-z","volume":"167","author":"P Tommiska","year":"2025","unstructured":"Tommiska P, Knuutinen O, L\u00f6nnrot K, Kivisaari R, Raj R, FINISH Investigators. Association between postoperative thromboembolic and hemorrhagic complications and clinical outcomes after surgery for chronic subdural hematoma in patients with anticoagulation therapy for atrial fibrillation. Acta Neurochir (Wien). 2025;167:17.","journal-title":"Acta Neurochir (Wien)"},{"key":"9133_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2017.10.091","volume":"109","author":"K Phan","year":"2018","unstructured":"Phan K, Abi-Hanna D, Kerferd J, Lu VM, Dmytriw AA, Ho Y-T, et al. Resumption of antithrombotic agents in chronic subdural hematoma: a systematic review and meta-analysis. World Neurosurg. 2018;109:e792\u20139.","journal-title":"World Neurosurg"},{"key":"9133_CR30","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1089\/neu.2011.2074","volume":"29","author":"JY Yeon","year":"2012","unstructured":"Yeon JY, Kong D-S, Hong S-C. Safety of early warfarin resumption following burr hole drainage for warfarin-associated subacute or chronic subdural hemorrhage. J Neurotrauma. 2012;29:1334\u201341.","journal-title":"J Neurotrauma"},{"key":"9133_CR31","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.wneu.2017.07.044","volume":"106","author":"J Bartek","year":"2017","unstructured":"Bartek J, Sj\u00e5vik K, Kristiansson H, St\u00e5hl F, Fornebo I, F\u00f6rander P, et al. Predictors of recurrence and complications after chronic subdural hematoma surgery: a population-based study. World Neurosurg. 2017;106:609\u201314.","journal-title":"World Neurosurg"},{"key":"9133_CR32","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1080\/02688690120097822","volume":"15","author":"V Gonugunta","year":"2001","unstructured":"Gonugunta V, Buxton N. Warfarin and chronic subdural haematomas. Br J Neurosurg. 2001;15:514\u20137.","journal-title":"Br J Neurosurg"},{"key":"9133_CR33","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.jocn.2021.05.036","volume":"89","author":"JJY Zhang","year":"2021","unstructured":"Zhang JJY, Aw NMY, Tan CH, Lee KS, Chen VHE, Wang S, et al. Impact of time to resumption of antithrombotic therapy on outcomes after surgical evacuation of chronic subdural hematoma: a multicenter cohort study. J Clin Neurosci. 2021;89:389\u201396.","journal-title":"J Clin Neurosci"},{"key":"9133_CR34","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.clineuro.2012.10.008","volume":"115","author":"OP Aspegren","year":"2013","unstructured":"Aspegren OP, \u00c5strand R, Lundgren MI, Romner B. Anticoagulation therapy a risk factor for the development of chronic subdural hematoma. Clin Neurol Neurosurg. 2013;115:981\u20134.","journal-title":"Clin Neurol Neurosurg"},{"key":"9133_CR35","doi-asserted-by":"crossref","unstructured":"Ohba S, Kinoshita Y, Nakagawa T, Murakami H. The risk factors for recurrence of chronic subdural hematoma. Neurosurg Rev. 2013;36:145\u20139; discussion 149\u2013150.","DOI":"10.1007\/s10143-012-0396-z"},{"key":"9133_CR36","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3171\/2016.8.JNS16134","volume":"127","author":"PM Brennan","year":"2017","unstructured":"Brennan PM, Kolias AG, Joannides AJ, Shapey J, Marcus HJ, Gregson BA, et al. The management and outcome for patients with chronic subdural hematoma: a prospective, multicenter, observational cohort study in the United Kingdom. J Neurosurg. 2017;127:732\u20139.","journal-title":"J Neurosurg"},{"key":"9133_CR37","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.jocn.2015.03.064","volume":"22","author":"H-A Leroy","year":"2015","unstructured":"Leroy H-A, Abouka\u00efs R, Reyns N, Bourgeois P, Labreuche J, Duhamel A, et al. Predictors of functional outcomes and recurrence of chronic subdural hematomas. J Clin Neurosci. 2015;22:1895\u2013900.","journal-title":"J Clin Neurosci"},{"key":"9133_CR38","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1179\/1743132815Y.0000000083","volume":"37","author":"Y Honda","year":"2015","unstructured":"Honda Y, Sorimachi T, Momose H, Takizawa K, Inokuchi S, Matsumae M. Chronic subdural haematoma associated with disturbance of consciousness: significance of acute-on-chronic subdural haematoma. Neurol Res. 2015;37:985\u201392.","journal-title":"Neurol Res"},{"key":"9133_CR39","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s00701-012-1399-9","volume":"154","author":"K-H Chon","year":"2012","unstructured":"Chon K-H, Lee J-M, Koh E-J, Choi H-Y. Independent predictors for recurrence of chronic subdural hematoma. Acta Neurochir (Wien). 2012;154:1541\u20138.","journal-title":"Acta Neurochir (Wien)"},{"key":"9133_CR40","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3340\/jkns.2019.0194","volume":"63","author":"J Choi","year":"2020","unstructured":"Choi J, Pyen J, Cho S, Kim J, Koo Y, Whang K. Influence of antithrombotic medication on the risk of chronic subdural hematoma recurrence after burr-hole surgery. J Korean Neurosurg Soc. 2020;63:513\u20138.","journal-title":"J Korean Neurosurg Soc"},{"key":"9133_CR41","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00701-015-2625-z","volume":"158","author":"HW Ro","year":"2016","unstructured":"Ro HW, Park SK, Jang DK, Yoon WS, Jang KS, Han YM. Preoperative predictive factors for surgical and functional outcomes in chronic subdural hematoma. Acta Neurochir (Wien). 2016;158:135\u20139.","journal-title":"Acta Neurochir (Wien)"},{"key":"9133_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2021.106817","volume":"208","author":"X Yu","year":"2021","unstructured":"Yu X, Wu L, Ou Y, Xu L, Guo X, Yang C, et al. Clinical characteristics and outcomes of chronic subdural hematoma in patients with a history of antiplatelet therapy. Clin Neurol Neurosurg. 2021;208:106817.","journal-title":"Clin Neurol Neurosurg"},{"key":"9133_CR43","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1007\/s00068-019-01258-3","volume":"47","author":"O Ren\u00e9","year":"2021","unstructured":"Ren\u00e9 O, Martin H, Pavol S, Kristi\u00e1n V, Tom\u00e1\u0161 F, Branislav K. Factors influencing the results of surgical therapy of non-acute subdural haematomas. Eur J Trauma Emerg Surg. 2021;47:1649\u201355.","journal-title":"Eur J Trauma Emerg Surg"},{"key":"9133_CR44","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1111\/ggi.13436","volume":"18","author":"K Shimizu","year":"2018","unstructured":"Shimizu K, Sadatomo T, Hara T, Onishi S, Yuki K, Kurisu K. Importance of frailty evaluation in the prediction of the prognosis of patients with chronic subdural hematoma. Geriatr Gerontol Int. 2018;18:1173\u20136.","journal-title":"Geriatr Gerontol Int"},{"key":"9133_CR45","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s10143-024-02493-y","volume":"47","author":"S Hounkpatin","year":"2024","unstructured":"Hounkpatin S, Stierer M, Frechon P, Rault F, Kelani A, Emery E, et al. Comparative analysis of surgical techniques in the management of chronic subdural hematomas and risk factors for poor outcomes. Neurosurg Rev. 2024;47:254.","journal-title":"Neurosurg Rev"},{"key":"9133_CR46","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1056\/NEJMoa2401201","volume":"391","author":"J Liu","year":"2024","unstructured":"Liu J, Ni W, Zuo Q, Yang H, Peng Y, Lin Z, et al. Middle meningeal artery embolization for nonacute subdural hematoma. N Engl J Med. 2024;391:1901\u201312.","journal-title":"N Engl J Med"},{"key":"9133_CR47","unstructured":"Fiorella D, Monteith SJ, Hanel R, Atchie B, Boo S, McTaggart RA, et al. Embolization of the Middle Meningeal Artery for Chronic Subdural Hematoma. N Engl J Med. 2024;391. Available from: https:\/\/www.nejm.org\/doi\/doi\/full\/10.1056\/NEJMoa2409845. Cited 21 Nov 2024."},{"key":"9133_CR48","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1056\/NEJMoa2313472","volume":"391","author":"JM Davies","year":"2024","unstructured":"Davies JM, Knopman J, Mokin M, Hassan AE, Harbaugh RE, Khalessi A, et al. Adjunctive middle meningeal artery embolization for subdural hematoma. N Engl J Med. 2024;391:1890\u2013900.","journal-title":"N Engl J Med"},{"key":"9133_CR49","doi-asserted-by":"crossref","unstructured":"Chan AW, Tetzlaff JM, G\u00f8tzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586","DOI":"10.1136\/bmj.e7586"},{"key":"9133_CR50","doi-asserted-by":"publisher","first-page":"e017559","DOI":"10.1161\/JAHA.120.017559","volume":"9","author":"A Chen","year":"2020","unstructured":"Chen A, Stecker EA, Warden B. Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges. J Am Heart Assoc. 2020;9:e017559.","journal-title":"J Am Heart Assoc."},{"key":"9133_CR51","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/jama.2024.21972","volume":"333","author":"World Medical Association","year":"2025","unstructured":"World Medical Association. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human participants. JAMA. 2025;333:71\u20134.","journal-title":"JAMA"},{"key":"9133_CR52","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afaf056","volume":"54","author":"R Raj","year":"2025","unstructured":"Raj R, Tommiska P, Luoto T, Leinonen V, Koivisto T, Tetri S, et al. Failure to improve-identifying risk factors for poor functional recovery following chronic subdural hematoma surgery. Age Ageing. 2025;54:afaf056.","journal-title":"Age Ageing"},{"key":"9133_CR53","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3171\/2021.10.JNS211608","volume":"137","author":"TSR Jensen","year":"2021","unstructured":"Jensen TSR, Haldrup M, Gr\u00f8nh\u00f8j MH, Miscov R, Larsen CC, Debrabant B, et al. National randomized clinical trial on subdural drainage time after chronic subdural hematoma evacuation. J Neurosurg. 2021;137:799\u2013806.","journal-title":"J Neurosurg"},{"key":"9133_CR54","doi-asserted-by":"publisher","first-page":"e565","DOI":"10.1016\/j.wneu.2020.10.140","volume":"146","author":"D Sale","year":"2021","unstructured":"Sale D. Single versus double burr hole for drainage of chronic subdural hematoma: randomized controlled study. World Neurosurg. 2021;146:e565\u20137.","journal-title":"World Neurosurg"},{"key":"9133_CR55","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.wneu.2017.04.154","volume":"104","author":"D Pinggera","year":"2017","unstructured":"Pinggera D, Unterhofer C, G\u00f6rtz P, Thom\u00e9 C, Ortler M. Postoperative thromboembolic prophylaxis with low-molecular-weight heparin and risk of rebleeding in patients with chronic subdural hematomas: a comparative retrospective cohort study. World Neurosurg. 2017;104:284\u201390.","journal-title":"World Neurosurg"},{"key":"9133_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;95:103208.","journal-title":"J Biomed Inform"},{"key":"9133_CR57","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377\u201381.","journal-title":"J Biomed Inform"},{"key":"9133_CR58","doi-asserted-by":"publisher","first-page":"e855","DOI":"10.1016\/j.wneu.2018.08.177","volume":"120","author":"SM Ryu","year":"2018","unstructured":"Ryu SM, Yeon JY, Kong D-S, Hong S-C. Risk of recurrent chronic subdural hematoma associated with early warfarin resumption: a matched cohort study. World Neurosurg. 2018;120:e855\u201362.","journal-title":"World Neurosurg"},{"key":"9133_CR59","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.jacc.2016.11.024","volume":"69","author":"JU Doherty","year":"2017","unstructured":"Doherty JU, Gluckman TJ, Hucker WJ, Januzzi JL, Ortel TL, Saxonhouse SJ, et al. 2017 ACC Expert Consensus Decision Pathway for Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation: A Report of the American College of Cardiology Clinical Expert Consensus Document Task Force. J Am Coll Cardiol. 2017;69:871\u201398.","journal-title":"J Am Coll Cardiol"},{"key":"9133_CR60","doi-asserted-by":"publisher","first-page":"e207","DOI":"10.1016\/j.chest.2022.07.025","volume":"162","author":"JD Douketis","year":"2022","unstructured":"Douketis JD, Spyropoulos AC, Murad MH, Arcelus JI, Dager WE, Dunn AS, et al. Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline. Chest. 2022;162:e207\u201343.","journal-title":"Chest"},{"key":"9133_CR61","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDra2200322","volume":"2","author":"JD Douketis","year":"2023","unstructured":"Douketis JD, Spyropoulos AC. Perioperative management of anticoagulant and antiplatelet therapy. NEJM Evid. 2023;2:EVIDra2200322.","journal-title":"NEJM Evid"},{"key":"9133_CR62","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1001\/jamainternmed.2019.2431","volume":"179","author":"JD Douketis","year":"2019","unstructured":"Douketis JD, Spyropoulos AC, Duncan J, Carrier M, Le Gal G, Tafur AJ, et al. Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant. JAMA Intern Med. 2019;179:1469\u201378.","journal-title":"JAMA Intern Med"},{"key":"9133_CR63","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.4581","volume":"7","author":"ALE Halme","year":"2024","unstructured":"Halme ALE, Roshanov PS, Tornberg SV, Lavikainen LI, Devereaux PJ, Tikkinen KAO, et al. Timing of Major Postoperative Bleeding Among Patients Undergoing Surgery. JAMA Netw Open. 2024;7:e244581.","journal-title":"JAMA Netw Open"},{"key":"9133_CR64","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/jth.12613","volume":"12","author":"S Schulman","year":"2014","unstructured":"Schulman S, Hwang H-G, Eikelboom JW, Kearon C, Pai M, Delaney J. Loading dose vs. maintenance dose of warfarin for reinitiation after invasive procedures: a randomized trial. J Thromb Haemost. 2014;12:1254\u20139.","journal-title":"J Thromb Haemost"},{"key":"9133_CR65","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s11239-017-1553-6","volume":"44","author":"TJ Bungard","year":"2017","unstructured":"Bungard TJ, Mutch J, Ritchie B. A randomized trial of restarting warfarin at maintenance versus loading doses following an elective procedure. J Thromb Thrombolysis. 2017;44:507\u201315.","journal-title":"J Thromb Thrombolysis"},{"key":"9133_CR66","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1227\/neu.0000000000002625","volume":"94","author":"K El Naamani","year":"2024","unstructured":"El Naamani K, Abbas R, Ghanem M, Mounzer M, Tjoumakaris SI, Gooch MR, et al. Resuming anticoagulants in patients with intracranial hemorrhage: a meta-analysis and literature review. Neurosurgery. 2024;94:14\u20139.","journal-title":"Neurosurgery"},{"issue":"7","key":"9133_CR67","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.jclinepi.2013.11.011","volume":"67","author":"TLN J\u00e4rvinen","year":"2014","unstructured":"J\u00e4rvinen TLN, Sihvonen R, Bhandari M, Sprague S, Malmivaara A, Paavola M, et al. Blinded interpretation of study results can feasibly and effectively diminish interpretation bias. J Clin Epidemiol. 2014;67(7):769\u201372.","journal-title":"J Clin Epidemiol"},{"key":"9133_CR68","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.genhosppsych.2021.12.012","volume":"74","author":"K Teppo","year":"2022","unstructured":"Teppo K, Jaakkola J, Airaksinen KEJ, Biancari F, Halminen O, Putaala J, et al. Mental health conditions and adherence to direct oral anticoagulants in patients with incident atrial fibrillation: a nationwide cohort study. Gen Hosp Psychiatry. 2022;74:88\u201393.","journal-title":"Gen Hosp Psychiatry"},{"key":"9133_CR69","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.961","volume":"10","author":"K Teppo","year":"2022","unstructured":"Teppo K, Jaakkola J, Biancari F, Halminen O, Linna M, Haukka J, et al. Association of income and educational levels with adherence to direct oral anticoagulant therapy in patients with incident atrial fibrillation: a Finnish nationwide cohort study. Pharmacol Res Perspect. 2022;10:e00961.","journal-title":"Pharmacol Res Perspect"},{"key":"9133_CR70","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1055\/s-0038-1651587","volume":"69","author":"FR Rosendaal","year":"1993","unstructured":"Rosendaal FR, Cannegieter SC, van der Meer FJ, Bri\u00ebt E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993;69:236\u20139.","journal-title":"Thromb Haemost"},{"key":"9133_CR71","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883\u201391.","journal-title":"N Engl J Med"},{"key":"9133_CR72","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","volume":"361","author":"SJ Connolly","year":"2009","unstructured":"Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139\u201351.","journal-title":"N Engl J Med"},{"key":"9133_CR73","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","volume":"365","author":"CB Granger","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJV, Lopes RD, Hylek EM, Hanna M, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365:981\u201392.","journal-title":"N Engl J Med"},{"key":"9133_CR74","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","volume":"369","author":"RP Giugliano","year":"2013","unstructured":"Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369:2093\u2013104.","journal-title":"N Engl J Med"},{"key":"9133_CR75","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1056\/NEJMoa2303048","volume":"388","author":"U Fischer","year":"2023","unstructured":"Fischer U, Koga M, Strbian D, Branca M, Abend S, Trelle S, et al. Early versus later anticoagulation for stroke with atrial fibrillation. N Engl J Med. 2023;388:2411\u201321.","journal-title":"N Engl J Med"},{"key":"9133_CR76","unstructured":"European Medicines Agency. ICH Topic 9: Statistical Principles for Clinical Trials. 2006;1998:37."},{"key":"9133_CR77","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1136\/bmj.330.7491.594","volume":"330","author":"VM Montori","year":"2005","unstructured":"Montori VM, Permanyer-Miralda G, Ferreira-Gonz\u00e1lez I, Busse JW, Pacheco-Huergo V, Bryant D, et al. Validity of composite end points in clinical trials. BMJ. 2005;330:594\u20136.","journal-title":"BMJ"},{"key":"9133_CR78","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1161\/STR.0b013e318296aeca","volume":"44","author":"RL Sacco","year":"2013","unstructured":"Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JJB, Culebras A, et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2013;44:2064\u201389.","journal-title":"Stroke"},{"issue":"18","key":"9133_CR79","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","volume":"72","author":"K Thygesen","year":"2018","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol. 2018;72(18):2231\u201364.","journal-title":"J Am Coll Cardiol"},{"key":"9133_CR80","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.ahj.2009.11.025","volume":"159","author":"ROCKET AF Study Investigators","year":"2010","unstructured":"ROCKET AF Study Investigators. Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study. Am Heart J. 2010;159:340-347.e1.","journal-title":"Am Heart J"},{"key":"9133_CR81","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"S Schulman","year":"2005","unstructured":"Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005;3:692\u20134.","journal-title":"J Thromb Haemost"},{"key":"9133_CR82","unstructured":"Socialstyrelsen D of R and S. Statistical register\u2019s production and quality National Cause of Death Register. 2022. Report No.: Item no.: 2022\u20135\u20137909. Available from: https:\/\/www.socialstyrelsen.se\/globalassets\/sharepoint-dokument\/dokument-webb\/ovrigt\/production-and-quality-dors.pdf."},{"key":"9133_CR83","unstructured":"European Medicines Agency. ICH Topic E 2 A. Clinical Safety Data Management: Definitions and Standards for Expedited Reporting. 1995. Available from: https:\/\/www.ema.europa.eu\/en\/ich-e2a-clinical-safety-data-management-definitions-standards-expedited-reporting-scientific-guideline#:~:text=01\/06\/1995-,View,-Related%20content."},{"key":"9133_CR84","first-page":"381","volume":"10","author":"V Jormanainen","year":"2018","unstructured":"Jormanainen V. Large-scale implementation and adoption of the Finnish national Kanta services in 2010\u20132017: a prospective, longitudinal, indicator-based study. Finn J eHealth eWelfare. 2018;10:381\u201395.","journal-title":"Finn J eHealth eWelfare"},{"key":"9133_CR85","unstructured":"Statistics Finland. Official Statistics of Finland (OSF): Causes of death [online publication]. 2022. Available from: https:\/\/stat.fi\/en\/statistics\/ksyyt."},{"key":"9133_CR86","unstructured":"Socialstyrelsen. National Cause of Death Register. 2024. Available from: https:\/\/www.socialstyrelsen.se\/en\/statistics-and-data\/registers\/national-cause-of-death--register\/."},{"key":"9133_CR87","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.thromres.2016.01.004","volume":"139","author":"JD Douketis","year":"2016","unstructured":"Douketis JD, Healey JS, Brueckmann M, Fraessdorf M, Spyropoulos AC, Wallentin L, et al. Urgent surgery or procedures in patients taking dabigatran or warfarin: analysis of perioperative outcomes from the RE-LY trial. Thromb Res. 2016;139:77\u201381.","journal-title":"Thromb Res"},{"key":"9133_CR88","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2307\/2530245","volume":"35","author":"PC O\u2019Brien","year":"1979","unstructured":"O\u2019Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics. 1979;35:549\u201356.","journal-title":"Biometrics"},{"key":"9133_CR89","unstructured":"StataCorp. Adaptive Designs: Group Sequential Trials Reference Manual, Release 18. Stata Press; 2023. Available from: https:\/\/www.stata.com\/bookstore\/adaptive-designs-reference-manual\/. Cited 4 Oct 2024."},{"key":"9133_CR90","doi-asserted-by":"publisher","first-page":"659","DOI":"10.2307\/2336502","volume":"70","author":"KKG Lan","year":"1983","unstructured":"Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika. 1983;70:659\u201363.","journal-title":"Biometrika"},{"key":"9133_CR91","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1056\/NEJMoa1305189","volume":"369","author":"R Sihvonen","year":"2013","unstructured":"Sihvonen R, Paavola M, Malmivaara A, Itala A, Joukainen A, Nurmi H, et al. Arthroscopic partial meniscectomy versus sham surgery for a degenerative meniscal tear. N Engl J Med. 2013;369:2515\u201324.","journal-title":"N Engl J Med"},{"key":"9133_CR92","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k2860","volume":"362","author":"M Paavola","year":"2018","unstructured":"Paavola M, Malmivaara A, Taimela S, Kanto K, Inkinen J, Kalske J, et al. Subacromial decompression versus diagnostic arthroscopy for shoulder impingement: randomised, placebo surgery controlled clinical trial. BMJ. 2018;362:k2860.","journal-title":"BMJ"},{"issue":"7","key":"9133_CR93","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.jclinepi.2013.11.011","volume":"67","author":"TLN Jarvinen","year":"2014","unstructured":"Jarvinen TLN, Sihvonen R, Bhandari M, Sprague S, Malmivaara A, Paavola M, et al. Blinded interpretation of study results can feasibly and effectively diminish interpretation bias. J Clin Epidemiol. 2014;67(7):769\u201372.","journal-title":"J Clin Epidemiol"},{"key":"9133_CR94","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-090224","volume":"14","author":"A Mansouri","year":"2024","unstructured":"Mansouri A, Nassiri F, Scales D, Pirouzmand F. Anticoagulation therapy timing in patients with atrial fibrillation after acute and chronic subdural haematoma (ATTAACH): a pilot randomised controlled trial. BMJ Open. 2024;14:e090224.","journal-title":"BMJ Open"},{"key":"9133_CR95","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1007\/s00701-020-04278-w","volume":"162","author":"M Rauhala","year":"2020","unstructured":"Rauhala M, Hel\u00e9n P, Sepp\u00e4 K, Huhtala H, Iverson GL, Niskakangas T, et al. Long-term excess mortality after chronic subdural hematoma. Acta Neurochir (Wien). 2020;162:1467\u201378.","journal-title":"Acta Neurochir (Wien)"},{"key":"9133_CR96","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3171\/2014.12.JNS141189","volume":"123","author":"CH Pang","year":"2015","unstructured":"Pang CH, Lee SE, Kim CH, Kim JE, Kang H-S, Park C-K, et al. Acute intracranial bleeding and recurrence after bur hole craniostomy for chronic subdural hematoma. J Neurosurg. 2015;123:65\u201374.","journal-title":"J Neurosurg"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09133-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-09133-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09133-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T20:03:12Z","timestamp":1763409792000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-025-09133-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":96,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9133"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-09133-w","relation":{},"ISSN":["1745-6215"],"issn-type":[{"type":"electronic","value":"1745-6215"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"13 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"515"}}